Intrexon | XON - Capitale Sociale E Riserve





Capitale Sociale E Riserve Cambiamento Data
Agenus USD -199.08M 22.15M 2026-06
Alaunos Therapeutics USD 652K 636K 2026-06
Amgen USD 14.35B 2.66B 2026-09
Anika Therapeutics USD 137.28M 3.38M 2026-06
Arrowhead Research USD 465.53M 148.45M 2026-06
AstraZeneca USD 51.73B 1.43B 2026-09
Bristol-Myers Squibb USD 23.4B 1.08B 2026-09
Gilead Sciences USD 13.04B 1.3B 2026-09
GlaxoSmithKline GBP 18.75B 1.11B 2026-09
Heron Therapeutics USD 6.91M 2.23M 2026-06
Incyte USD 5.64B 701.49M 2026-09
Intrexon USD 43.17M 75.33M 2024-06
Karyopharm Therapeutics USD -265.65M 27.28M 2026-03
Ligand Pharmaceuticals USD 961.76M 5.75M 2026-09
MacroGenics USD 42.87M 21.68M 2026-06
MannKind USD -37.27M 29.93M 2026-09
Merck USD 44.89B 2.96B 2026-09
Novartis USD 37.23B 4.72B 2026-09
Rigel Pharmaceuticals USD 117.61M 35.67M 2025-09
Roche Holding CHF 32.69B 1.11B 2026-06
Sangamo BioSciences USD 19.6M 14.7M 2025-06
Thermo Fisher Scientific USD 54.76B 2.08B 2026-09
Veracyte USD 1.43B 44.86M 2026-09
Xencor USD 560.43M 57.21M 2026-09